SOURCE: Durrie Vision

Durrie Vision

April 18, 2015 10:00 ET

Durrie Vision First in Region to Provide Corneal Implant Designed to Treat Presbyopia

Announcement Follows FDA's Approval of the AcuFocus KAMRA Inlay

OVERLAND PARK, KS--(Marketwired - April 18, 2015) - Durrie Vision, a Kansas City-based ophthalmology and refractive surgery practice, will be the first in the area to provide KAMRA Vision™, a new procedure designed to treat presbyopia, a condition causing the loss of near vision. The announcement follows the FDA's recent approval of the AcuFocus KAMRA inlay, a small device implanted in the cornea, proven to be the only surgical treatment for presbyopia to improve near and intermediate vision while maintaining stereopsis, or distance vision. Durrie Vision, led by Dr. Daniel Durrie and Dr. Jason Stahl, was involved in all three stages of the clinical trials and is pleased to make the procedure more widely available.

According to the American Academy of Ophthalmology, more than 1 billion people worldwide suffer from presbyopia. Affecting people in their 40s, presbyopia results in a loss of near vision, making it difficult to read up close and to perform near tasks without the dependence on reading glasses or bifocals. By improving depth of focus and restoring near vision, the KAMRA inlay delivers a lasting solution for people struggling with this condition. Ideal candidates for the KAMRA inlay are between the ages of 45 and 60, have difficulty reading small print or seeing near objects, and require reading glasses with +1.00 to +2.50 diopters of power.

As a research site for all three stages of the clinical trials, Durrie Vision is uniquely prepared to launch this innovative procedure in the Kansas City region. Dr. Durrie, who served as an investigator in the trials, reiterates the importance of Durrie Vision's participation in the research: "This is a significant advantage for Durrie Vision and our patients. We have participated in all the stages of the KAMRA clinical studies and have done more procedures than any other center in the U.S. We have been following the first procedures for over seven years. Because of this we know which patients are the best candidates, the best surgical techniques and the appropriate follow-up needed."

Dr. Durrie has also been involved in the international development of the procedure, which is now approved in over 40 countries. The KAMRA inlay is the only FDA approved corneal inlay and has been implanted over 20,000 times worldwide.

About Durrie Vision
Durrie Vision, in Overland Park, is a world-class refractive surgery center and research department located in the heart of America. At Durrie Vision, our focus is providing exceptional outcomes within a world-class patient experience. Our laser vision correction options, such as advanced LASIK and refractive lens procedures, have helped thousands of people enjoy better vision. We are committed to excellence because the world turns to us for answers, and our patients turn to us for the best quality of care and technology available. Our refractive surgeons -- Dr. Daniel S Durrie, Dr. Jason E Stahl, and Dr. Timothy P. Lindquist -- are among the most experienced refractive surgeons in the country with international reputations and innovators and leaders in the field.

For more information about Durrie Vision, please visit DurrieVision.com or facebook.com/durrievision

To view the original source of this press release, click here:
http://www.durrievision.com/durrie-vision-first-in-kansas-city-metro-to-provide-corneal-implant-designed-to-treat-presbyopia

Image Available: http://www.marketwire.com/library/MwGo/2015/4/18/11G038850/Images/Stahl_Durrie-329329060171.jpg

Contact Information